These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Myocardial and coronary endothelial protective effects of acetylcholine after myocardial ischaemia and reperfusion in rats: role of nitric oxide. Richard V, Blanc T, Kaeffer N, Tron C, Thuillez C. Br J Pharmacol; 1995 Aug; 115(8):1532-8. PubMed ID: 8564215 [Abstract] [Full Text] [Related]
43. Attenuation of myocardial ischaemic injury 24 h after diacylglycerol treatment in vivo. Baxter GF, Mocanu MM, Yellon DM. J Mol Cell Cardiol; 1997 Jul; 29(7):1967-75. PubMed ID: 9236150 [Abstract] [Full Text] [Related]
44. Direct detrimental effects of L-arginine upon ischemia--reperfusion injury to myocardium. Takeuchi K, McGowan FX, Danh HC, Glynn P, Simplaceanu E, del Nido PJ. J Mol Cell Cardiol; 1995 Jul; 27(7):1405-14. PubMed ID: 7473786 [Abstract] [Full Text] [Related]
49. A1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia. Zhao ZQ, Nakanishi K, McGee DS, Tan P, Vinten-Johansen J. Cardiovasc Res; 1994 Feb; 28(2):270-9. PubMed ID: 8143310 [Abstract] [Full Text] [Related]
50. [Effects of Xuefu Zhuyu Capsule on endothelin-1 release in myocardium and vascular endothelium and nitric oxide/nitric oxide synthase system of swines after acute myocardial infarction and reperfusion]. Hou XL, Li BL, Zhao L, Huang SD, Xu ZY, Zhang GX. Zhong Xi Yi Jie He Xue Bao; 2008 Apr; 6(4):381-6. PubMed ID: 18405606 [Abstract] [Full Text] [Related]
51. Nitric oxide/cGMP signalling mediates the cardioprotective action of adrenomedullin in reperfused myocardium. Hamid SA, Totzeck M, Drexhage C, Thompson I, Fowkes RC, Rassaf T, Baxter GF. Basic Res Cardiol; 2010 Mar; 105(2):257-66. PubMed ID: 19714395 [Abstract] [Full Text] [Related]
52. Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. Jung C, Gonon AT, Sjöquist PO, Lundberg JO, Pernow J. Cardiovasc Res; 2010 Jan 01; 85(1):147-54. PubMed ID: 19726439 [Abstract] [Full Text] [Related]
53. Reduction of infarct size and infiltration of polymorphonuclear leukocytes by a thromboxane synthetase inhibitor. Studies in a rabbit ischemic heart model. Ito T, Asai F, Ushiyama S, Matsuda K, Oshima T. Arzneimittelforschung; 1990 Jan 01; 40(1):23-7. PubMed ID: 1692704 [Abstract] [Full Text] [Related]
56. Desflurane-induced preconditioning against myocardial infarction is mediated by nitric oxide. Smul TM, Lange M, Redel A, Burkhard N, Roewer N, Kehl F. Anesthesiology; 2006 Oct 01; 105(4):719-25. PubMed ID: 17006071 [Abstract] [Full Text] [Related]
57. A chimeric IgG4 monoclonal antibody directed against CD18 reduces infarct size in a primate model of myocardial ischemia and reperfusion. Aversano T, Zhou W, Nedelman M, Nakada M, Weisman H. J Am Coll Cardiol; 1995 Mar 01; 25(3):781-8. PubMed ID: 7860929 [Abstract] [Full Text] [Related]
58. Short-acting calcium antagonist clevidipine protects against reperfusion injury via local nitric oxide-related mechanisms in the jeopardised myocardium. Gourine A, Gonon A, Sjöquist PO, Pernow J. Cardiovasc Res; 2001 Jul 01; 51(1):100-7. PubMed ID: 11399252 [Abstract] [Full Text] [Related]